Polyhydroxyalkanoates (PHAs) are not manufactured through traditional chemical synthesis; they are biological metabolites "grown" within specialized cellular factories.
This bio-based origin necessitates a unique industrial workflow that merges microbiology with large-scale chemical engineering. The transition from a microscopic granule to a functional plastic pellet requires an analysis of the biological engines and the rigorous extraction processes involved.
Observation
PHA granules accumulating inside bacterial cytoplasm under electron microscopy.
Microbial Cell Factories: The Biological Engines
Cupriavidus necator
The industry benchmark. Capable of accumulating polymer loads reaching 80–90% of its dry cell weight with high-density yields.
Pseudomonas Strains
Primary source for medium-chain-length PHAs (mcl-PHA). Provides flexible, rubber-like consistency for specialized mechanical needs.
Halomonas & Recombinants
Thrive in high-salinity "open" systems. Engineered E. coli acts as a chassis for customized metabolic pathways.
Feedstock Evolution
The economic viability is heavily dependent on the "carbon source," typically accounting for 40–50% of total production costs.
| Source Type | Examples | Key Advantage |
|---|---|---|
| Agri-Byproducts | Molasses, rice bran, grape peels | Non-food competitive |
| Waste Lipids | Used Cooking Oils (UCO), animal fats | High energy density |
| C1 Carbon Capture | CH4 (Methane), CO₂ (Carbon Dioxide) | Carbon negative potential |
The Industrial Workflow
A two-phase cycle: Fermentation (Upstream) & Recovery (Downstream)
Upstream Processing
Fermentation Strategy
1. Growth Phase
Cells are provided with a balanced nutrient broth to build robust biomass density before the shift to synthesis.
2. Accumulation Phase
By inducing "nutrient stress" (limiting Nitrogen/Phosphorus), microbes shift metabolism to frantically convert excess carbon into internal PHA granules.
